HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rosella Tomanin Selected Research

Iduronic Acid (Iduronate)

1/2022Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy.
4/2019Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles.
11/2016Glial degeneration with oxidative damage drives neuronal demise in MPSII disease.
9/2014Clinical efficacy of enzyme replacement therapy in paediatric Hunter patients, an independent study of 3.5 years.
1/2014A Hunter Patient with a Severe Phenotype Reveals Two Large Deletions and Two Duplications Extending 1.2 Mb Distally to IDS Locus.
9/2013Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rosella Tomanin Research Topics

Disease

12Mucopolysaccharidosis II (Hunter Syndrome)
01/2022 - 11/2005
5Mucopolysaccharidoses
01/2022 - 03/2008
4Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy)
12/2018 - 03/2008
3Inborn Genetic Diseases (Disease, Hereditary)
03/2021 - 08/2014
2Mucopolysaccharidosis I (Hurler Syndrome)
12/2021 - 01/2016
2Disease Progression
03/2021 - 09/2014
2Lysosomal Storage Diseases (Lysosomal Storage Disease)
10/2013 - 03/2008
1Neuroinflammatory Diseases
05/2017
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016
1Central Nervous System Diseases (CNS Diseases)
01/2016
1Globoid Cell Leukodystrophy (Krabbe Disease)
08/2014
1Hyperoxia
11/2013
1Shock
10/2013
1Rare Diseases (Rare Disease)
03/2012
1Necrosis
03/2008

Drug/Important Bio-Agent (IBA)

15EnzymesIBA
12/2021 - 11/2005
13GlycosaminoglycansIBA
01/2022 - 11/2005
6Iduronic Acid (Iduronate)IBA
01/2022 - 09/2013
5HydrolasesIBA
01/2022 - 08/2014
5Dermatan SulfateIBA
12/2021 - 03/2008
4N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA
12/2018 - 03/2008
3Heparitin Sulfate (Heparan Sulfate)IBA
12/2021 - 11/2005
3Biomarkers (Surrogate Marker)IBA
12/2016 - 03/2008
2RNA (Ribonucleic Acid)IBA
05/2017 - 03/2008
2idursulfaseFDA Link
09/2014 - 12/2010
1Iduronidase (alpha-L-Iduronidase)IBA
12/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
03/2021
1CalciumIBA
05/2017
1Lysergic Acid Diethylamide (LSD)IBA
05/2017
1LigandsIBA
05/2017
1CateninsIBA
01/2017
1Uronic AcidsIBA
12/2016
1Proteins (Proteins, Gene)FDA Link
11/2013
1Interleukin-6 (Interleukin 6)IBA
11/2013
1Dihydrotachysterol (AT 10)IBA
10/2013
1Biological ProductsIBA
01/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2008

Therapy/Procedure

5Enzyme Replacement Therapy
01/2022 - 03/2008
2Therapeutics
09/2014 - 03/2008
1Hematopoietic Stem Cell Transplantation
08/2014
1Precision Medicine
03/2012